14^th Euro Breast Cancer and Therapeutics

About the Conference

Welcome to the 14th Euro Breast Cancer and Therapeutics Conference!

We are delighted to invite you to the 14th Euro Breast Cancer and Therapeutics Conference, taking place on December 07–08, 2026, in the vibrant city of Paris, France. This distinguished international event will bring together leading oncologists, breast surgeons, researchers, scientists, healthcare professionals, industry experts, and patient advocates from across the globe to exchange knowledge and explore the latest advancements in breast cancer research, diagnosis, and treatment.

Under the theme "Redefining Breast Cancer Treatment Through Global Collaboration and Innovation," the conference will feature inspiring keynote lectures, scientific presentations, interactive panel discussions, and engaging workshops highlighting breakthroughs in precision oncology, targeted therapies, immunotherapy, artificial intelligence in cancer care, molecular diagnostics, early detection, clinical trials, and survivorship. The program is designed to foster interdisciplinary collaboration and accelerate the translation of research into improved patient outcomes.

Whether your expertise is in clinical oncology, breast surgery, radiation oncology, pathology, genetics, translational research, pharmaceutical sciences, nursing, or patient-centered care, this conference provides an exceptional platform to present research, build international collaborations, exchange innovative ideas, and contribute to shaping the future of breast cancer therapeutics. Join us in Paris to connect with global leaders and be part of the next generation of advancements transforming breast cancer care.

Why Attend?

• Learn from internationally renowned experts in breast cancer research and treatment.

• Explore the latest advancements in precision oncology, targeted therapies, immunotherapy, and personalized medicine.

• Gain insights into innovative diagnostic technologies and emerging treatment strategies.

• Present your research and receive valuable feedback from global experts.

• Participate in keynote sessions, scientific presentations, workshops, and panel discussions.

• Network with oncologists, surgeons, researchers, clinicians, healthcare professionals, and industry leaders from around the world.

• Discover current trends in early detection, molecular diagnostics, clinical trials, and survivorship care.

• Build international collaborations for research, education, and clinical practice.

• Showcase your work through oral and poster presentations.

• Connect with leading academic institutions, research organizations, hospitals, and healthcare companies.

• Earn recognition for your research and expand your professional network.

• Exchange ideas and best practices that can improve patient outcomes.

• Stay updated on the latest guidelines, technologies, and evidence-based practices in breast cancer care.

• Explore opportunities for career development, partnerships, and future research collaborations.

• Contribute to advancing the future of breast cancer treatment through global collaboration and innovation.

Sessions and Tracks

1. Advancements in Early Detection and Precision Screening

This session highlights the latest innovations in breast cancer screening, including AI-assisted mammography, digital breast tomosynthesis, contrast-enhanced mammography, MRI, and liquid biopsy. Experts will discuss personalized screening strategies, risk prediction models, and technologies that improve early diagnosis, reduce false-positive rates, and enhance patient outcomes.

2. Precision Oncology and Genomic Medicine

Explore how genomic profiling, molecular diagnostics, and biomarker-driven approaches are transforming breast cancer management. Discussions will focus on BRCA mutations, HER2-low disease, multigene assays, circulating tumor DNA, and precision treatment strategies that enable personalized care and improved therapeutic outcomes.

3. Immunotherapy and Next-Generation Targeted Therapies

Discover the latest breakthroughs in immunotherapy and targeted therapies, including immune checkpoint inhibitors, antibody-drug conjugates, PARP inhibitors, CDK4/6 inhibitors, novel HER2-targeted agents, and combination therapies designed to overcome resistance and improve survival.

4. Triple-Negative Breast Cancer: New Frontiers in Treatment

This session examines advances in managing triple-negative breast cancer through molecular profiling, immunotherapy, targeted therapies, antibody-drug conjugates, and innovative clinical trials aimed at improving outcomes in this aggressive subtype.

5. Hormone Receptor-Positive Breast Cancer: Evolving Treatment Strategies

Learn about the latest developments in endocrine therapy, selective estrogen receptor degraders (SERDs), CDK4/6 inhibitors, PI3K inhibitors, resistance mechanisms, and personalized treatment approaches for hormone receptor-positive breast cancer.

6. HER2-Positive and HER2-Low Breast Cancer

Explore the rapidly evolving therapeutic landscape for HER2-positive and HER2-low breast cancers, including antibody-drug conjugates, tyrosine kinase inhibitors, emerging HER2-targeted therapies, and strategies to overcome treatment resistance.

7. Innovations in Breast Cancer Surgery

This session focuses on advances in breast-conserving surgery, oncoplastic procedures, reconstructive techniques, sentinel lymph node biopsy, robotic-assisted surgery, and personalized surgical planning to optimize both oncological and cosmetic outcomes.

8. Advances in Radiation Oncology

Discover the latest innovations in radiation therapy, including hypofractionated radiotherapy, proton therapy, adaptive radiation techniques, image-guided treatment, and combination strategies that maximize effectiveness while minimizing toxicity.

9. Breast Cancer in Young Women and Hereditary Syndromes

This session addresses the unique clinical and psychosocial challenges faced by younger women, including fertility preservation, hereditary breast cancer syndromes, genetic counseling, pregnancy-associated breast cancer, survivorship, and supportive care.

10. Metastatic Breast Cancer: Improving Survival and Quality of Life

Gain insights into the latest systemic therapies, precision medicine, supportive care, symptom management, and multidisciplinary approaches that improve both survival and quality of life for patients with metastatic breast cancer.

11. Breast Cancer Prevention and Risk Assessment

This session explores lifestyle interventions, genetic counseling, chemoprevention, risk prediction models, preventive surgery, and public health strategies designed to reduce breast cancer incidence and promote early intervention.

12. Artificial Intelligence, Digital Health, and Big Data in Breast Cancer Care

Explore the growing role of artificial intelligence, digital pathology, radiomics, telemedicine, wearable technologies, and predictive analytics in enhancing diagnosis, treatment planning, patient monitoring, and clinical decision-making.

13. Survivorship, Rehabilitation, and Supportive Care

Learn about comprehensive survivorship care, rehabilitation, mental health support, nutrition, exercise, lymphedema management, and interventions that improve long-term quality of life for breast cancer survivors.

14. Clinical Trials, Drug Discovery, and Translational Research

This session highlights the latest advances in drug discovery, translational research, adaptive clinical trial designs, biomarker-driven studies, and regulatory pathways that accelerate the development of innovative breast cancer therapies.

15. Global Collaboration and Equitable Breast Cancer Care

Aligned with the conference theme, this session explores international collaborations, global research partnerships, healthcare policies, and strategies to reduce disparities in breast cancer screening, diagnosis, treatment, and access to high-quality care worldwide.

Market Analysis

Breast cancer remains the most commonly diagnosed cancer among women worldwide, creating a growing demand for innovative diagnostic technologies, personalized therapies, and multidisciplinary treatment approaches. The increasing global incidence of breast cancer, combined with advancements in precision oncology, artificial intelligence, molecular diagnostics, and targeted therapeutics, continues to drive significant growth across the oncology sector.

The global breast cancer diagnostics market is estimated to reach USD 6.3 billion in 2026 and is projected to grow to approximately USD 11.4 billion by 2033, at a compound annual growth rate (CAGR) of 8.8%. Growth is fueled by increased screening programs, adoption of digital imaging technologies, AI-assisted diagnostics, liquid biopsy, and genomic testing.

Similarly, the global breast imaging market is expected to reach USD 6.4 billion in 2026 and expand at a CAGR of 9.7% through 2033. The adoption of digital breast tomosynthesis, contrast-enhanced mammography, MRI, and AI-powered imaging solutions is improving early detection while enhancing diagnostic accuracy.

Artificial intelligence is rapidly transforming oncology practice. The global AI in Oncology market is projected to reach USD 8.3 billion in 2026 and grow at a CAGR of 24.8% through 2033, driven by increasing demand for early cancer detection, precision medicine, digital pathology, predictive analytics, and clinical decision support systems. Breast cancer represents one of the leading application areas for AI-based innovations.

Recent international studies have demonstrated that AI-assisted breast cancer screening improves early detection while reducing the rate of interval cancers. Advances in genomic testing are also enabling clinicians to identify patients who can safely avoid unnecessary chemotherapy, further accelerating the transition toward personalized treatment strategies.

North America currently leads the global breast cancer diagnostics and imaging markets owing to strong healthcare infrastructure, extensive research investments, and widespread screening initiatives. Europe continues to be a major contributor through collaborative clinical research, precision oncology programs, and supportive regulatory frameworks. Meanwhile, the Asia-Pacific region is expected to witness the fastest growth due to expanding healthcare infrastructure, increasing cancer awareness, improved access to diagnostics, and rising healthcare expenditure.

The rapid evolution of breast cancer research, precision medicine, digital health technologies, immunotherapy, and international clinical collaborations highlights the growing importance of global scientific meetings. The 14th Euro Breast Cancer and Therapeutics Conference serves as a premier platform for researchers, clinicians, healthcare professionals, industry leaders, and policymakers to exchange knowledge, foster collaborations, and explore innovative solutions that will redefine breast cancer treatment through global collaboration and innovation.